A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19
Study sponsor: Enanta Pharmaceuticals, Inc · ENTA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-02-08Actual
Enrollment · participants231Actual
Source updated2024-08-19Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.